Cite
Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model
MLA
Cervantes-Villagrana, Alberto R., et al. “Prime-Boost BCG Vaccination with DNA Vaccines Based in β-Defensin-2 and Mycobacterial Antigens ESAT6 or Ag85B Improve Protection in a Tuberculosis Experimental Model.” Vaccine, vol. 31, no. 4, Jan. 2013, pp. 676–84. EBSCOhost, https://doi.org/10.1016/j.vaccine.2012.11.042.
APA
Cervantes-Villagrana, A. R., Hernández-Pando, R., Biragyn, A., Castañeda-Delgado, J., Bodogai, M., Martínez-Fierro, M., Sada, E., Trujillo, V., Enciso-Moreno, A., & Rivas-Santiago, B. (2013). Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model. Vaccine, 31(4), 676–684. https://doi.org/10.1016/j.vaccine.2012.11.042
Chicago
Cervantes-Villagrana, Alberto R., Rogelio Hernández-Pando, Arya Biragyn, Julio Castañeda-Delgado, Monica Bodogai, Margarita Martínez-Fierro, Eduardo Sada, Valentin Trujillo, Antonio Enciso-Moreno, and Bruno Rivas-Santiago. 2013. “Prime-Boost BCG Vaccination with DNA Vaccines Based in β-Defensin-2 and Mycobacterial Antigens ESAT6 or Ag85B Improve Protection in a Tuberculosis Experimental Model.” Vaccine 31 (4): 676–84. doi:10.1016/j.vaccine.2012.11.042.